Clinical profile of patients with cardiac amyloidosis in India

被引：5

作者：

Mohan, Bishav ^{[1
]}

Singh, Suvir ^{[2
,5
]}

Tandon, Rohit ^{[1
]}

Batta, Akash ^{[1
]}

Singal, Gautam ^{[1
]}

Singh, Gurbhej ^{[1
]}

Singh, Bhupinder ^{[1
,3
]}

Goyal, Abhishek ^{[1
]}

Chhabra, Shibba Takkar ^{[1
]}

Naved, Khizar ^{[4
]}

Jain, Aayush ^{[2
]}

Wander, Gurpreet S. ^{[1
]}

机构：

[1] Dayanand Med Coll & Hosp, Hero DMC Heart Inst, Unit, Ludhiana, India

[2] Dayanand Med Coll & Hosp, Ludhiana, India

[3] AIIMS, Bathinda, India

[4] Kasturba Med Coll & Hosp, Manipal, India

[5] Dayanand Med Coll & Hosp, Dept Clin Haematol & Stem Cell Transplantat, Ludhiana, India

来源：

INDIAN HEART JOURNAL | 2023年 / 75卷 / 01期

关键词：

Amyloid; Cardiac; Myeloma; TTR; Cancer; PRIMARY SYSTEMIC AMYLOIDOSIS;

D O I：

10.1016/j.ihj.2022.12.006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Limited data exists on patients with cardiac amyloidosis (CA) in India, due to underdiagnosis and late presentation. We present single centre data from 13 patients over a 4 year period with a median age of 65 years. A majority presented with symptomatic heart failure (69%) and eight patients had confirmed AL amyloidosis. At the end of the follow up period, 46% patients died, with 30% of the overall cohort dead within six months. Among the survivors, 71% continue to have NYHA grade III/IV symptoms. A suggested algorithm for earlier diagnosis in resource constrained settings is also presented.(c) 2022 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

引用

页码：73 / 76

页数：4

共 15 条

[1] Outcomes of autologous stem cell transplant for cardiac AL-amyloidosis and cardiac light chain deposition disease
Abdallah, Al-Ola A.
Alapat, Daisy
Kaur, Varinder
Atrash, Shebli
[J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (05) : 1128 - 1133
[2] Cardiac Amyloidosis in India: A Clinicopathological Study
Agarwal, Harsh
Ghosh, Tamoghna
Arava, Sudheer
Ray, Ruma
Seth, Sandeep
[J]. JOURNAL OF THE PRACTICE OF CARDIOVASCULAR SCIENCES, 2021, 7 (02) : 121 - 127
[3] Comprehensive Review of AL amyloidosis: some practical recommendations
Al Hamed, Rama
Bazarbachi, Abdul Hamid
Bazarbachi, Ali
Malard, Florent
Harousseau, Jean-Luc
Mohty, Mohamad
[J]. BLOOD CANCER JOURNAL, 2021, 11 (05)
[4] Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis
Aljama, Mohammed A.
Sidiqi, M. Hasib
Dispenzieri, Angela
Gertz, Morie A.
Lacy, Martha Q.
Buadi, Francis K.
Dingli, David
Muchtar, Eli
Fonder, Amie L.
Hayman, Suzanne R.
Hobbs, Miriam A.
Gonsalves, Wilson I.
Warsame, Rahma M.
Kourelis, Taxiarchis
Hwa, Yi Lisa
Kapoor, Prashant
Leung, Nelson
Go, Ronald S.
Kyle, Robert A.
Rajkumar, S. Vincent
Kumar, Shaji K.
[J]. BLOOD ADVANCES, 2019, 3 (08) : 1226 - 1229
[5] Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study
Chatzantonis, Grigorios
Bietenbeck, Michael
Elsanhoury, Ahmed
Tschope, Carsten
Pieske, Burkert
Tauscher, Gloria
Vietheer, Julia
Shomanova, Zornitsa
Mahrholdt, Heiko
Rolf, Andreas
Kelle, Sebastian
Yilmaz, Ali
[J]. CLINICAL RESEARCH IN CARDIOLOGY, 2021, 110 (04) : 555 - 568
[6] Amyloid diseases of the heart: assessment, diagnosis, and referral
Dubrey, S. W.
Hawkins, P. N.
Falk, R. H.
[J]. HEART, 2011, 97 (01) : 75 - 84
[7] Fitzgerald BT, 2017, IJC HEART VASC, V14, P53, DOI 10.1016/j.ijcha.2016.12.002
[8] Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement
Grogan, M
Gertz, MA
Kyle, RA
Tajik, AJ
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (05) : 664 - +
[9] Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis
Itzhaki Ben Zadok, Osnat
Vaturi, Mordehay
Vaxman, Iuliana
Iakobishvili, Zaza
Rhurman-Shahar, Noa
Kornowski, Ran
Hamdan, Ashraf
[J]. PLOS ONE, 2021, 16 (08):
[10] Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association
Kittleson, Michelle M.
Maurer, Mathew S.
Ambardekar, Amrut V.
Bullock-Palmer, Renee P.
Chang, Patricia P.
Eisen, Howard J.
Nair, Ajith P.
Nativi-Nicolau, Jose
Ruberg, Frederick L.
[J]. CIRCULATION, 2020, 142 (01) : E7 - E22

← 1 2 →